Literature DB >> 26408666

CCR5-Dependent Activation of mTORC1 Regulates Translation of Inducible NO Synthase and COX-2 during Encephalomyocarditis Virus Infection.

Zachary R Shaheen1, Aaron Naatz1, John A Corbett2.   

Abstract

Encephalomyocarditis virus (EMCV) infection of macrophages results in the expression of a number of inflammatory and antiviral genes, including inducible NO synthase (iNOS) and cyclooxygenase (COX)-2. EMCV-induced macrophage activation has been shown to require the presence of CCR5 and the activation of PI3K-dependent signaling cascades. The purpose of this study was to determine the role of PI3K in regulating the macrophage responses to EMCV. We show that PI3K regulates EMCV-stimulated iNOS and COX-2 expression by two independent mechanisms. In response to EMCV infection, Akt is activated and regulates the translation of iNOS and COX-2 through the mammalian target of rapamycin complex (mTORC)1. The activation of mTORC1 during EMCV infection is CCR5-dependent and appears to function in a manner that promotes the translation of iNOS and COX-2. CCR5-dependent mTORC1 activation functions as an antiviral response, as mTORC1 inhibition increases the expression of EMCV polymerase. PI3K also regulates the transcriptional induction of iNOS and COX-2 in response to EMCV infection by a mechanism that is independent of Akt and mTORC1 regulation. These findings indicate that macrophage expression of the inflammatory genes iNOS and COX-2 occurs via PI3K- and Akt-dependent translational control of mTORC1 and PI3K-dependent, Akt-independent transcriptional control.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26408666      PMCID: PMC4610876          DOI: 10.4049/jimmunol.1500704

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  69 in total

1.  Regulatory effects of mammalian target of rapamycin-activated pathways in type I and II interferon signaling.

Authors:  Surinder Kaur; Lakhvir Lal; Antonella Sassano; Beata Majchrzak-Kita; Maya Srikanth; Darren P Baker; Emmanuel Petroulakis; Nissim Hay; Nahum Sonenberg; Eleanor N Fish; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2006-11-17       Impact factor: 5.157

Review 2.  Mechanisms of type-I- and type-II-interferon-mediated signalling.

Authors:  Leonidas C Platanias
Journal:  Nat Rev Immunol       Date:  2005-05       Impact factor: 53.106

3.  Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40.

Authors:  Emilie Vander Haar; Seong-Il Lee; Sricharan Bandhakavi; Timothy J Griffin; Do-Hyung Kim
Journal:  Nat Cell Biol       Date:  2007-02-04       Impact factor: 28.824

4.  CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection.

Authors:  Jeffrey W Tyner; Osamu Uchida; Naohiro Kajiwara; Edy Y Kim; Anand C Patel; Mary P O'Sullivan; Michael J Walter; Reto A Schwendener; Donald N Cook; Theodore M Danoff; Michael J Holtzman
Journal:  Nat Med       Date:  2005-10-02       Impact factor: 53.440

5.  Encephalomyocarditis virus induces PKR-independent mitogen-activated protein kinase activation in macrophages.

Authors:  Jason M Moran; Michael A Moxley; R Mark L Buller; John A Corbett
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

6.  Role of MAPK in the regulation of double-stranded RNA- and encephalomyocarditis virus-induced cyclooxygenase-2 expression by macrophages.

Authors:  Sarah A Steer; Jason M Moran; Benjamin S Christmann; Leonard B Maggi; John A Corbett
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

Review 7.  Viruses cause type 1 diabetes in animals.

Authors:  Ji-Won Yoon; Hee-Sook Jun
Journal:  Ann N Y Acad Sci       Date:  2006-10       Impact factor: 5.691

8.  Genetic and pharmacologic evidence that calcium-independent phospholipase A2beta regulates virus-induced inducible nitric-oxide synthase expression by macrophages.

Authors:  Jason M Moran; R Mark L Buller; Jane McHowat; John Turk; Mary Wohltmann; Richard W Gross; John A Corbett
Journal:  J Biol Chem       Date:  2005-06-08       Impact factor: 5.157

9.  PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding.

Authors:  Lifu Wang; Thurl E Harris; Richard A Roth; John C Lawrence
Journal:  J Biol Chem       Date:  2007-05-17       Impact factor: 5.157

10.  Dendritic cell stimulation by mycobacterial Hsp70 is mediated through CCR5.

Authors:  R Andres Floto; Paul A MacAry; Jessica M Boname; Tan Suet Mien; Beate Kampmann; James R Hair; Oh Seen Huey; Edith N G Houben; Jean Pieters; Cheryl Day; Wulf Oehlmann; Mahavir Singh; Kenneth G C Smith; Paul J Lehner
Journal:  Science       Date:  2006-10-20       Impact factor: 47.728

View more
  5 in total

Review 1.  Co-receptor signaling in the pathogenesis of neuroHIV.

Authors:  E A Nickoloff-Bybel; L Festa; O Meucci; P J Gaskill
Journal:  Retrovirology       Date:  2021-08-24       Impact factor: 4.602

Review 2.  Beyond HIV infection: Neglected and varied impacts of CCR5 and CCR5Δ32 on viral diseases.

Authors:  Joel Henrique Ellwanger; Bruna Kulmann-Leal; Valéria de Lima Kaminski; Andressa Gonçalves Rodrigues; Marcelo Alves de Souza Bragatte; José Artur Bogo Chies
Journal:  Virus Res       Date:  2020-05-30       Impact factor: 3.303

Review 3.  Pathogens MenTORing Macrophages and Dendritic Cells: Manipulation of mTOR and Cellular Metabolism to Promote Immune Escape.

Authors:  Lonneke V Nouwen; Bart Everts
Journal:  Cells       Date:  2020-01-09       Impact factor: 6.600

4.  STAT3 Differentially Regulates TLR4-Mediated Inflammatory Responses in Early or Late Phases.

Authors:  Akash Ahuja; Eunji Kim; Gi-Ho Sung; Jae Youl Cho
Journal:  Int J Mol Sci       Date:  2020-10-16       Impact factor: 5.923

5.  Anisomycin protects against sepsis by attenuating IκB kinase-dependent NF-κB activation and inflammatory gene expression.

Authors:  Gyoung Lim Park; Minkyung Park; Jeong-Ki Min; Young-Jun Park; Su Wol Chung; Seon-Jin Lee
Journal:  BMB Rep       Date:  2021-11       Impact factor: 4.778

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.